Investigative Techniques: News and Research on Clinical Studies as Topic

MeSH tree: E05.318.372.250

FDA approves Exdensur for severe asthma

The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult and pediatric patients aged 12 years and older.

page 2 from 27